Tartrate-resistant acid phosphatase (TRAP) is an iron-containing protein encoded by the same gene that codes for uteroferrin, a placental iron transport protein. In human peripheral mononuclear cells, TRAP expression is inhibited by both hemin (ferric protoporphyrin IX) and protoporphyrin IX. Nuclear run-on assays confirmed that this inhibition occurs at the level of gene transcription. Previous studies with mTRAP deletion mutants showed that the hemin effect was dependent on repressor activity in the mTRAP 5"flanking region at -1846 bp t o -1240 bp relative t o ATG (Reddy et al, J Bone Mineral Res 10:601, 1995). We now report that gel shift assays showed a DNA binding protein in nuclear extracts of hemin-treated cells termed hemin response element binding protein (HREBP). Additional studies have localized the HREBP binding region in the mTRAP 5"flanking DNA t o a 27-bp sequence at -1815 t o -1789 bp relative t o ATG. A tandem repeat sequence, GAGGC;GAGGC, contained within this DNA segment, was shown t o be involved in binding of HREBP. Highly homologous sequences are ARTRATE-RESISTANT acid phosphatase (TRAP), the type 5 iso-enzyme of acid phosphatase, is expressed predominantly in differentiated cells of the mononuclear phagocyte system such as alveolar macrophages and osteoclasts,' and its expression can be induced in peripheral monocytes by culture in medium supplemented by serum with or without phorbol diesters.* TRAP expression is pathologically increased in the cells of patients with hairy cell leukemia and in the spleens and serum of patients with Gaucher's disease. ' Evidence suggests that TRAP may function in iron homeostasis.' TRAP is an iron-containing protein, also known as purple acid phosphatase (PAP),' and it shares approximately 85% sequence homology with porcine uteroferrin, a placental iron transport p r~t e i n .~ TRAP and uteroferrin appear to represent a single gene Recent studies in our laboratory indicated that expression of the TRAP gene is enhanced by iron and that this regulation is mediated at the level of gene transcription.' Transfection experiments with chimeric murine TRAP (mTRAP)-luciferase reporter gene constructs showed that iron responsiveness is contained within a 600-bp segment of the mTRAP 5"flanking region from -1846 to -1240 bp relative to ATG.7,8 Induction of TRAP mRNA is inhibited by hemin (ferric protoporphyrin IX) and by protoporphyrin IX. This inhibition also is dependent on nucleotide sequences in the mTRAP 5"flanking region from -1846 to -1240 bp.8 We now report that hemidprotoporphyrin-responsive inhibition is mediated by interaction of a nuclear protein in extracts of hemin-treated cells with a specific nucleotide sequence in the mTRAP 5"flanking region. Highly homologous nucleotide sequences are present in the human TRAP gene. The heminresponsive protein shares homology with the HAPl transcriptional factor of the yeast, Saccharomyces cerevisiae,' because the interaction with binding site oligonucleotides can be blocked by anti-HAP1 antibody. These data establish the existence of a hemin-responsive transcriptional regulatory mechanism in mammalian cells and suggest an important role for hemin and protoporphyrin compounds in the control of certain cellular functions.
present in the 5'-flanking region of the hTRAP gene. Binding of HREBP to the mTRAP DNA sequence was inhibited by anti-HAP1 antibodies, indicating homology between the hemin-responsive factor and the yeast heme-dependent transcription factor, HAPl. A 607-bp segment of the mTRAP 5'-flanking region containing the candidate hemin response element and surrounding sequences conferred hemin regulation on the viral SV40 promoter. Southwestern blotting experiments probing nuclear extracts of hemin-treated U937 cells with the 27-bp binding sequence showed t w o protein bands at 37 and 133 kD representing candidate HREBPs. A GENINFO search showed several other mammalian genes with tandem GAGGC motifs in noncoding regions, providing the possibility that additional genes may also be regulated by hemin at the level of transcription. These studies provide the first description of a novel iron/hemin-responsive transcriptional regulatory mechanism in mammalian cells. 0 1996 b y The American Society of Hematology.
the level of gene transcription. ' Transfection experiments with chimeric murine TRAP (mTRAP)-luciferase reporter gene constructs showed that iron responsiveness is contained within a 600-bp segment of the mTRAP 5"flanking region from -1846 to -1240 bp relative to ATG. 7, 8 Induction of TRAP mRNA is inhibited by hemin (ferric protoporphyrin IX) and by protoporphyrin IX. This inhibition also is dependent on nucleotide sequences in the mTRAP 5"flanking region from -1846 to -1240 bp. 8 We now report that hemidprotoporphyrin-responsive inhibition is mediated by interaction of a nuclear protein in extracts of hemin-treated cells with a specific nucleotide sequence in the mTRAP 5"flanking region. Highly homologous nucleotide sequences are present in the human TRAP gene. The heminresponsive protein shares homology with the HAPl transcriptional factor of the yeast, Saccharomyces cerevisiae, ' because the interaction with binding site oligonucleotides can be blocked by anti-HAP1 antibody. These data establish the existence of a hemin-responsive transcriptional regulatory mechanism in mammalian cells and suggest an important role for hemin and protoporphyrin compounds in the control of certain cellular functions.
MATERIALS AND METHODS

Preparation of human peripheral mononuclear cell (PMC) populations and cell cultures.
PMCs were isolated from the venous blood of healthy volunteers by density sedimentation on ficoll-Hypaque." To assess TRAP expression, PMCs were incubated for various times at 37% in 5% CO2 in RPM1 medium containing 2 mmoY L L-glutamine and 10% heat-inactivated fetal bovine serum (FBS) with no additions or 50 pnol/L hemin or protoporphyrin IX.
RNA hybridization analyses. Total cellular RNA was isolated by a modification of the guanidinium isothiocyanate technique." Integrity of RNA was assessed by visualization of ethidium bromidestained gels. Total cellular RNA was fractionated by electrophoresis through a 1% (wt/vol) agarose gel containing formaldehyde and then transferred to nitrocellulose filters presoaked in 20X SSC (SSC = For personal use only. on October 3, 2017. by guest www.bloodjournal.org From were hybridized with 3zP-oligolabeled cDNA probes. After washing, the filters were exposed to Kodak XAR film (Eastman Kodak, Rochester, NY) at -70-C with Dupont Cronex intensifying screens (Dupont, Wilmington, DE). Relative intensities of blots on autoradiography were quantified by scanning densitometry.
Three cDNA probes were used: a full-length human placental TRAP cDNA probe of 1,412 bp3; a 3.8-kb EcoRI-HindIII fragment from the human a-actin genomic clone, HA4l'; and a 2.2-kb cathepsin D cDNA probe containing the procathepsin D coding seq~ence.'~ Nuclear transcription assay. Active nuclei from human PMCs were isolated as described by Marzluff and Huang14 using lysis buffer consisting of 0.32 m& sucrose in 3 mmoVL CaCI,, 2 mmoV L magnesium acetate, 0.1 mmol/L EDTA, 0.1% Triton-X-100, 1 . The final RNA product was precipitated overnight in 2 v01 of ethanol and recovered after two washes in 70% ethanol. Labeled RNA (10 to 20 X lo6 cpm) was hybridized to nitrocellulose filters containing 5 pg of immobilized DNA in halving dilutions. Filters were prehybridized for 1 hour at 45'C and hybridized with RNA for 3 days at 45'C in 50% formamide, 0.1% sodium dodecyl sulfate (SDS), 50 pg/mL tRNA, 6 x SSC, 0.1 % NaPiPOa I 2X Denhardt's solution without bovine serum albumin (BSA), and 10% dextran sulfate. Filters were washed in three changes of 2 x SSC, 0.1% NaPiPO,, and 0.1% SDS for 10 minutes at 26'C. A high stringency wash then was performed at 65°C in two changes of 0.2% SSC, 0.1% SDS for 30 minutes each. Filters were air-dried for 30 minutes and then autoradiography was performed as described above. In preliminary experiments, a-amanitin (2 pg/ mL) inhibited transcription of genes for TRAP and cathepsin D, but not of the gene for 28s rRNA.
Gel retardation assays. We used the technique of Andrews and Faller16 to extract DNA-binding proteins. Briefly, HRE H9 or U937 cells (5 X l@ to 1 X 10') were suspended in 400 pL of cold 10 0.5 mmol/L dithiothreitol, and 0.2 mmol/L PMSF for a IO-minute swelling period at 4%. After vortexing and centrifugation to release and pellet the nuclei, the pellet was suspended in 20 to 100 pL of cold 20 mmol/L HEPES-KOH, pH 7.9, 25% glycerol, 420 mmoVL NaCI, 1.5 mmom MgCI,, 0.2 mmol/L EDTA, 0.5 mmol/L dithiothreitol, and 0.2 mmol/L PMSF and extracted for 20 minutes at 4%. After centrifugation at 4-C to remove debris, the supernatant fraction containing DNA binding proteins was recovered. DNA probes (10 pmol/L) were radiolabeled with 10 mCi/mL y-"P (specific activity, 3,000 Ci/mmol) by reaction with T4 polynucleotide kinase for 30 minutes at 37%. The reaction was stopped with 0.5 m o m EDTA, and probes were purified by phenokhloroform extraction and ethanol precipitation. Probes were suspended in TE buffer and used in binding reactions (l0,OOO to 20,000 cpm) with 2 to 10 pg nuclear extract protein incubated at 37% for 30 minutes with BSA and poly-(dI-dC). After incubation, reaction mixtures were analyzed by electrophoresis in a 4% low ionic strength native polyacrylamide Transfection assays. The mTRAP-luciferase fusion gene (pKB5) was constructed as previously described by insertion of mTRAP sequences from the region -1846 to +2 bp into the Kpn YBgl II sites of a promoter-deficient pGL2 basic vector containing the luciferase reporter gene."
The rabbit endometrial cell line, HRE H9, was used for transfection experiments because it is known to be permissive for mTRAP promoter constructs, and mouse cell lines permissive for TRAP expression have not been de~cribed.'~ We have previously shown the transcriptional regulation of mTRAP promoter activity by hemin and iron in HRE H9 cells transiently transfected with luciferase reporter gene constructs.' HRE H9 cells were plated at a density of 2 X lo6 cells/lOO-mm dish in a Minimal Essential Medium with 10% FBS 24 hours before transfection using the CaPO, method (Stratagene, La Jolla, CA). For transfections, 15 pg of cesium chloride gradientpurified plasmids was used. Cotransfection with pRSV P-galactosidase was performed as a control for transfection efficiency.'" To develop stably transfected cell lines, the neomycin-resistant plasmid PWL neo (Stratagene) was cotransfected with TRAP-luciferase plasmids at a 1:3 molar ratio. Cells were exposed for 16 hours to the CaPOJDNA precipitate, washed twice with serum-free medium, fed with fresh culture medium supplemented with 10% FBS, and then incubated for 48 hours at 37% in 5% CO,. G418 treatment (400 pg/mL) was applied 48 hours after the removal of DNA from the cultures and was maintained for 30 days before beginning the experiments. Stable clones bearing constructs of interest were derived by limiting dilution.
To test the response to hemin, transfectants were incubated for 48 hours with or without hemin (50 pmol/L). After incubation, the cell monolayer was washed twice with phosphate-buffered saline and incubated at room temperature for 15 minutes with 0.3 mL celllysis reagent (25 mmoVL Tris, pH 7.8, 2 mmol/L dithiothreitol, 2 mmoVL 1 ,2-diaminocyclohexanene-NNN'N'-tetra-acetic acid, 10% [voVvoll glycerol, and 1% [voUvol] Triton X-100). The monolayer was scraped and spun briefly in a microcentrifuge to pellet the debris. 
RESULTS
Effect of hemin or protoporphyrin IX on expression of
TRAP mRNA in PMC cultures. Figure 1 shows a representative experiment examining the appearance of TRAP mRNA transcripts in cultures of human PMCs incubated with or without the addition of hemin (50 pmoVL). The marked induction of TRAP mRNA transcripts seen after 48 hours in control cultures was blocked by the addition of hemin. We have previously shown that induction of TRAP mRNA and enzyme activity in these cultures is localized to the monocyte-macrophage component of the PMC population.' Figure 2 shows the results of an identical experiment performed with protoporphyrin IX or cobalt protoporphyrin IX in place of hemin. Inhibition of TRAP mRNA expression again was observed. Cell viability, as judged by trypan blue exclusion, was not different among cultures with hemin, protoporphyrin IX, cobalt protoporphyrin, or controls and always exceeded 95% at 48 hours. To determine whether the TRAP mRNA induction observed in the PMC cultures was transcriptionally mediated, we performed nuclear runon assays using nuclei isolated from untreated or hemintreated PMCs (Fig 3) . The results of these experiments indicated that both the induction and also the hemin inhibition of TRAP mRNA expression in PMCs in vitro are mediated at the level of gene transcription. use gene constructs. To examine the effect of hemin on TRAP transcription in more detail, we prepared promoted reporter mTRAPAuciferase gene constructs and performed transfection experiments into the HRE H9 cell line. This cell line derived from rabbit endometrium was chosen because it has been used by us and others to study TRAP reg~lation.'.".'~ Based on these previous data, HRE H9 cells were known to be capable of expressing and regulating transfected TRAP genes, although they do not express endogenous TRAP. The 5"flanking region of the mTRAP gene has promoter activity that is responsive to iron and hemin.'.* Incubation with hemin of stable HRE H9 transfectants bearing a full-length (-1846 to +2 bp) mTRAP promoter linked to a luciferase reporter inhibited luciferase activity by greater than 50% (Fig 4A) . By contrast, transfectants bearing promoterheporter constructs with only -330 to +2 bp of the mTRAP 5"flanking region were not inhibited by hemin. The hemin inhibition was blocked by incubation with excess 27-bp oligonucleotides derived from the mTRAP 5"flanking region (discussed in detail below) but not by irrelevant oligos (Fig 4A) . In the transfection experiments (Fig 4) , inhibition by hemin was less than that seen in the primary PMC culture system (Fig 1) . A basic difference between the transfected cells and primary culture system is that there is a constitutive baseline level of luciferase activity driven by the mTRAP promoter in the stable transfectants, whereas, in the human PMCs, the TRAP gene is not expressed under baseline conditions. We considered the possibility that hemin inhibition might be more effective in blocking induction of TRAP expression than suppressing transcription once the gene has become transcriptionally active. Therefore, we performed the experiments shown in Fig 4B. In these experiments, hemin was added to PMC cultures after 24 hours of induction rather than at the time of culture initiation, as in Fig 1. The results show that hemin, added to cultures after 24 hours of incubation, can blunt but not block completely the level of TRAP mRNA in PMC cultures. In fact, the level of inhibition in these experiments (60% to 70%) closely approximates the inhibition seen in the transfection experiments in Fig 4A  (approximately 50% to 60%) .
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with the interpretation that hemin is most effective at blocking induction of gene expression. One must also consider that residual mRNA from the initial induction period may partially contribute to the results seen in Fig 4B. And, we cannot exclude the possibility that additional hemin-responsive elements may be located elsewhere in the mTRAP gene. Nonetheless, taken together, the data in Fig 4 suggest that the mTRAP 5"flanking region contains specific sequences that mediate hemin inhibition of mTRAP expression.
Gel retardation experiments. To search for hemin-responsive DNA binding proteins that might mediate transcriptional inhibition of TRAP expression, we performed gel retardation assays using nuclear extracts from control and hemin-treated cells. Initially HRE H9 nuclei were used to document the presence of such proteins in cells that we knew regulated TRAP expression.
However, we were interested in studying this regulation in human cells. We have recently cloned the human TRAP gene:' and Fleckenstein et a122 have elucidated the genomic structure of hTRAP. Sequencing of the 5"flanking region to -3026 bp relative to ATG showed two separate GAGGC repeats separated in one instance by 1 bp and in the other by 3 bp. These two areas are homologous to the mTRAP candidate hemin response element described below and may represent the analogous human element. Based on these observations, we have used nuclear extracts from human U937 monocytic cell? with mTRAP oligonucleotide probes for the gel retardation assays described below. As with HRE H9 cells, U937 cells do not possess endogenous TRAP, but they do possess hemin-responsive DNA binding proteins, and they are derived from the monocyte lineage that is known to express TRAP in vivo. ' We used a strategy of deletion mutagenesis to identify a candidate hemin response element in the mTRAP 5"flanking region. Initial gel shift assays showed protein binding to a 254-bp probe corresponding to -1843 to -1590 bp of the mTRAP 5"flanking region after incubation with nuclear extracts from hemin-treated U937 cells. Controls to confirm the specificity of this observation included competition experiments with excess unlabeled relevant and irrelevant oligos and gel shift experiments with radiolabeled irrelevant oligos. Also, simple addition of hemin to nuclear extracts from untreated cells did not reproduce the gel shifts. These data indicated that a DNA binding site(s) for a potential transcriptional repressor(s) was contained within this segment. The data also suggested that incubation of cells with hemin was required for induction or activation of this factor. shift pattern with increased binding of at least one higher molecular weight protein to the radiolabeled probe (Fig 5A) . Binding was blocked by excess cold relevant but not irrelevant probe. Figure 5B shows that similar DNA binding proteins are present in human PMCs. These data provide evidence that a DNA binding site for a nuclear protein termed hemin response element binding protein (HREBP) is present at this location in the mTRAP 5"flanking region. Additional experiments were performed to confirm the specificity of this interaction (Fig 6) . In these experiments, 20-fold molar excess of different oligonucleotides derived from the 27-bp sequence were used as cold competitors in gel mobility assays. The results indicate that GAGGC completely abolished and GCAGG partially inhibited the observed gel shift. By contrast, no to minimal inhibition was given by either CCTTG or TAATG. These experiments provide strong evidence that the GAGGC tandem repeat at -1809 to -l800 bp of the mTRAP 5"flanking region is involved in the binding of a nuclear factor (HREBP) expressed in hemin treated cells. However, sequences in addition to the tandem GAGGC Rabbit polyclonal antibody to the zinc finger domain of HAPI inhibited binding of HREBP to the 27-bp probe, whereas nonimmune rabbit serum did not. These data suggest that the hemindependent nuclear factor (HREBP) may share homology with HAPl. Because the gel shift results showed inhibition and not a supershift, it is suggested that both the antibody interaction and the homology are present in the DNA binding domains of HREBP and HAPI.
Identification of a hemin-responsive nuclear DNA binding protein by Southwestern blotting. Figure 8 depicts results of Southwestern blotting experiments in which protein blots representing nuclear extracts from hemin-treated U937 cells separated by SDS-PAGE were probed with radiolabeled 27-bp binding site oligonucleotides from the mTRAP 5"flanking region. The results delineate protein bands of apparent molecular weights of 133 and 37 Kd. Both bands were decreased by excess unlabeled relevant but not irrelevant probe. Rabbit polyclonal anti-HAPI antibody blocked delineation of the 133-Kd protein by the 27-bp probe, whereas nonimmune rabbit serum did not. Figure 8 also shows that both the 133-and 37-Kd proteins are present in normal human PMCs after hemin treatment. The lower panel of Fig 8 shows that binding of radiolabeled native 27-bp probe to the 133-Kd protein was not blocked by excess cold probe identical to the native 27-mer except for containing a scrambled GAG-GCGAGGC sequence. This observation points both to the specificity of binding and also to the importance of the tandem GAGGC sequences to the interaction.
Functional studies of the mTRAP DNA binding site for a hemin-responsive protein. Heterologous promoter experiments were performed to show the functional significance of the 27-bp putative hemin response element (Fig 9) . In those experiments, we cloned a 607-bp segment of the mTRAP 5"flanking region containing the 27-bp candidate binding site (-1846 to -1240 bp) or an irrelevant 626-bp segment (+ l349 to +l975 bp relative to ATG) upstream of the SV40 viral promoter in the pGL2 promoter vector. Transient transfections into HRE H9 cells were performed with cotransfection of pRSV &galactosidase serving as control for transfection efficiency. Hemin treatment caused significant inhibition of luciferase activity in transfectants with the relevant construct, but not in those with the irrelevant construct (Fig 9) . This level of inhibition averaged 60%, which is the same as that produced by hemin in the promoted reporter transfection experiments (Fig 4) . Based on our previous studies, we know that this portion of the mTRAP promoter has no endogenous promoter activity, but does contain iron-and hemin-responsive elements.'.' Although consistent with this interpretation, these experiments do not conclusively indicate that the 27-bp binding site is the important sequence for mediating hemin inhibition. Therefore, we have performed blocking experiments with the 27-mer candidate binding motif, as shown in Fig 4. These experiments show that hemin inhibition of luciferase activity in stable transfectants with promoterhciferase constructs was specifically blocked by incubation with excess 27-mer, but not by an irrelevant oligonucleotide. This observation provides additional evidence that this sequence and its binding protein are involved in hemin inhibition.
DISCUSSION
These experiments provide identification and the first description of a unique hemidprotoporphyrin-dependent transcriptional regulatory mechanism in mammalian cells. We have reported previously that the TRAP gene is transcriptionally upregulated by iron provided as diferric transferrin (FeTF),' and we now report that, conversely, TRAP expres- Heterologous promoter experiments. A 607-bp oligonucleotide corresponding t o -1846 bp to -1240 bp of the mTRAP 5"flanking region was ligated into the pGU promoter vector using the kpnl/ bglZrestriction sites upstream of the SV40 promoter. Transient transfections were performed into HRE H9 cells, and transfectants were treated with hemin (50 pmollLI. Luciferase activity was determined in a luminometer. Parallel control experiments used an irrelevant 626-bp oligo corresponding to +l349 to +l975 bp of mTRAP. Results depict the mean 2 SD of three determinations. Means for unmodified pGL2 promoter and the 607-bp construct differed significantly ( P = .0028). Relative luciferase activity refers to the ratio of luciferase activity in hemin-treatedluntreated HRE H9 cells. Cotransfection with pRSV P-galactosidase was included in these experiments as a control for transfection efficiency.
sion is downregulated by hemin (femc protoporphyrin IX) or protophorphyrin IX. Hemin and protoporphyrin IX each substantially inhibited TRAP mRNA expression in human PMCs (Figs 1 and 2 ). Inhibition by both hemin and protoporphyrin IX provides strong evidence that the protoporphyrin moiety, and not the iron, was responsible for mediating this effect. This provides an explanation for the apparent paradox that hemin, a potential iron source, nonetheless blocks irondependent TRAP induction.
The results of nuclear transcription assays (Fig 3) and transfection experiments with mTRAPAuciferase promoted reporter constructs (Fig 4) indicate that the hemin/protopor-2295 Human platelet-derived growth factor (PDGF-A)=
GTPase26
phyrin inhibition is mediated at the level of gene transcription. Using gel retardation assays, a binding site for an apparent hemin-responsive nuclear regulatory factor was identified in a 27-bp segment of the mTRAP 5"flanking region at bp -18 15 to -1789 relative to ATG (Fig 5) . The binding site contains a tandem repeat sequence, GAGGC;GAGGC, that appears to be involved in binding of the factor (Figs 6 and  8 ). Using the 27-bp binding site oligonucleotide as a probe, two protein bands have been identified in Southwestern blots from nuclear extracts of hemin-treated cells and represent the putative hemin-dependent nuclear regulatory factor(s), termed HREBP (Fig 8) .
To show the hemin-dependent repressor function of the DNA binding site, heterologous promoter experiments were performed. In these experiments, a 607-bp segment of the mTRAP 5"flanking region containing the binding site and its flanking components conferred hemin responsiveness on the SV40 promoter in the pGL2 promoter vector (Fig 9) . In other experiments, incubation of stable transfectants bearing a full-length mTRAP-luciferase construct with excess binding site oligonucleotide blocked hemin-dependent regulation of luciferase expression (Fig 4) . These experiments documented the relationship between the binding site identified by gel retardation experiments and the functional outcome of hemin-dependent transcriptional inhibition.
The present results increase our understanding of the mTRAP promoter. The 5"flanking region of mTRAP lacks a TATA box and contains an intron directly flanking the ATG." There are numerous candidate transcription factor binding sequences, including those for SPI, API, and H-APF-1. I' Although a putative iron response element has been identified in the 5"flanking region of the porcine uterofemn For personal use only. on October 3, 2017. by guest www.bloodjournal.org From gene,25 no similar candidate iron response elements have been identified in the mTF2AP 5'-flanking We have previously developed 5' and 3' deletion mutants of the mTRAP 5"flanking region fused to a luciferase reporter gene to characterize regulation of TRAP expression.8 Transcriptional regulation of the mTRAP gene is complex. Two nonoverlapping regions of the 1.8-kb 5'-flanking region had promoter activity. An upstream promoter, PI, was located within the region from -881 bp to -463 bp relative to the ATG, whereas a downstream promoter, P2, was located in the intronic region between -363 bp and -1 bp. FeTF increased PI promoter activity 2.5-fold and hemin decreased P, promoter activity, but neither had any effect on P2 activity. Putative enhancers and suppressors for the P2 promoter were identified at -962 to -881 bp and at -1846 to -1240 bp, respectively. Based on those data and the data in this report, we have constructed a model for ironhemin-responsive regulation of mTRAP expression (Fig 10) .
To assess the generality of this type of regulation, we conducted a GenBank search for genes with significant homology to the 27-bp mTRAP candidate hemin response element. A large number of genes were identified, including 8 mammalian genes containing GAGGC tandem repeats in noncoding region^.^^.^^ Recently, Fleckenstein et a1 identified candidate tandem repeat GAGGC sequences in the 5"flanking region of the hTRAP gene. These genes are listed in Table 1 . They represent additional genes that may be under hemin transcriptional regulation. We also have evidence that the human protein kinase C , B (PKCP) gene is regulated in a similar fashion by i r~n '~.~~ and hemin (unpublished observation). However, the ironhemin response area of the PKCp gene is located in the 5'-untranslated region in an area for which nucleotide sequence data are not presently available. Therefore, it appears that there may be a family of mammalian genes that are regulated in similar fashion by iron and hemin. However, additional studies will be required to determine whether these genes are, in fact, regulated by hemin.
It is of interest that binding of HREBP to mTRAP 5'-flanking DNA was inhibited by anti-HAP1 antibody (Fig 7) . HAPI, a yeast protein that mediates heme activation of gene transcription, is a member of the GAL4 zinc finger class of transcription factors.' Zhang and G~a r e n t e~~ have defined the consensus DNA binding sequence for HAPl as a direct repeat of two CGG triplets with a 6 nucleotide spacer containing a critical TA sequence. Although the candidate mTRAP hemin response element contains two GGC triplets, HAPl does not bind to this inverted sequence,36 so that the two proteins may differ in their DNA binding requirements. An additional difference is that HAPl requires an interaction with heme to permit DNA binding: whereas HREBP appears to have a different mechanism of action, because prolonged incubation of cells with hemin appears necessary for its interaction with oligonucleotide probes. Therefore, although differences from the yeast HAPl system clearly exist, our data suggest that hemin regulation may be involved in expression of mammalian genes as well. However, additional studies are required to elucidate the relationship of HREBP to HAPl and to better understand the molecular mechanism by which it may interact with hemin to mediate inhibition of transcription.
